Gene transfer and kidney disease

Journal of Nephrology

Volumn 11, Issue 1, 1998, Pages 16-19

  Imai, Enyu ^a   Isaka, Yoshitaka ^a   Akagi, Yoshitaka ^a   Kaneda, Yasufumi ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Gene therapy; HVJ liposome; TGF

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DECORIN; IMMUNOGLOBULIN G; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

EXTRACELLULAR MATRIX; GENE TRANSFER; GENETIC MANIPULATION; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DISEASE; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PROTEIN DOMAIN; REVIEW;

GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; KIDNEY DISEASES; OLIGONUCLEOTIDES, ANTISENSE; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RESPIROVIRUS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031966443     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Klahr S, Schreiner G, Ichiklawa I. The progression of renal disease N Engl J Med 1988; 318: 1657-66.
2. Johnson R, Floege J, Couser W, Alpers C. Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 1992; 4: 119-28.
3. Abboud H: Growth factors in glomerulonephritis. Kidney Int 1993; 43: 252-67.
4. Border WA, Nobel NA, Languino L. Mechanisms of tissue injury and repair. In: Schrier R, Gottschalk C, eds. Disease of the kidney. Boston: Little, Brown and Company, 1997.
5. Sterzel R, Rupprecht H, Glomerular mesangial cells. In: Neilson E, Couser W, eds. Immunologic renal diseases. Philadelphia: Lippincott-Raven Publishers, 1997.
6. Yamamoto T, Noble NA, Cohen A, et al. Expression of transforming growth factor-b isoforms in human glomerular diseases. Kidney Int 199; 49: 461-9.
7. Niemer Z, Stein H, Noronha I, Kruger C, Andrassy K, Waldherr R. PDGF and TGF-ß contribute to the natural course of human IgA glomerulonephritis. Kidney Int 1995; 48: 150-41.
8. Border WA, Nable NA. Transforming growth factor in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.
9. Alpers C, Seifert R, Hudkins K, Johnson R, Bowen P. PDGF-receptor localized to mesangial, epithelial, and interstitial cells in human primate kidneys. Kidney Int 1993; 43: 286-94.
10. Iida H, Seifert R, Alpers C, et al. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc Natl Acad Sci USA 1991; 88: 6560-4.
11. Okuda S, Languino L, Ruoslahti E, Border W. Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990; 453-62.
12. Border W, Okuda S, Languino L, Sporn M, Ruoslahti E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor ß1. Nature 1990; 346: 371-4.
13. Johnson R, Raines E, Floege J, et al. Inhibition of mesngial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 1992; 175: 1413-6.
14. Okada Y. Sendai virus-induced cell fusion. Methods Enzymol 1993 221: 18-41.
15. Kaneda Y, Morishita R, Tomita N. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. J Mol Med 1995; 73: 289-97.
16. Akagi Y, Isaka Y, Arai M, et al. Inhibition of TGF-ß1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 1996; 50: 148-55.
17. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta of platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993; 92: 2597-601.
18. Kopp J, Factor V, Mozes M, et al. Transgenic mice with increased plasma levels of TGF-ß1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003.
19. Border W, Noble N, Yamamoto T, et al. Natural inhibitor of transforming growth factor-ß protects against scarring in experimental kidney disease. Nature 1992; 360: 361-4.
20. Isaka Y, Brees DK, Ikegaya K, et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2: 418-23.
21. Lin H, Wang X, Ng E, Weinberg R, Lodish H. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992; 68: 775-85.
22. Miyazono K, ten Dijke P, Yamashita H, Heldin G. Signal transduction via serine/threonine kinase receptors. Semin Cell Biol 1994; 5: 389-98.
23. Warna J, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-beta receptor. Nature 1994; 370: 341-7.
24. ten Dijke P, Yamashita H, Sampath T, et al. Identification of type I receptors for osteogenic protein-1 and bone morphogenic protein-4. J Biol Chem 1994; 269: 16985-8.
25. Knaus P, Lindemann D, DeCoteau J, et al. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 1996; 16: 3480-9.
26. Lin H, Moustakas A, Knaus P, Wells R, Henis Y, Lodish H. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands. J Biol Chem 1995; 270: 2747-54.
27. Isaka Y, Alcagi Y, Ando, et al. Gene therapy by transforming growth factor-b receptor IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. J Am Soc Nephrol 1997; 7: 1735.